Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Equillium Inc (EQ)

Equillium Inc (EQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Equillium Inc 2223 Avenida de la Playa Suite 105 LA JOLLA CA 92037 USA

www.equilliumbio.com Employees: 35 P: 858-240-1200

Sector:

Medical

Description:

Equillium, Inc. is a biotechnology company. It develops products for autoimmune and inflammatory disorders. The company's product pipeline consists of EQ001 which is in clinical-stage. Equillium, Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 94,384
Enterprise Value, $K 76,294
Shares Outstanding, K 60,893
Float, K 41,651
% Float 68.40%
Short Interest, K 1,473
Short Float 2.42%
Days to Cover 2.43
Short Volume Ratio 0.51
% of Insider Shareholders 31.60%
% of Institutional Shareholders 27.05%

Financials:

Annual Sales, $ 41,100 K
Annual Net Income, $ -8,070 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,230 K
EBIT, $ -24,380 K
EBITDA, $ -25,000 K

Growth:

1-Year Return 79.95%
3-Year Return 39.64%
5-Year Return -83.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 84.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -0.62
EPS Growth vs. Prev Qtr 62.50%
EPS Growth vs. Prev Year 342.23%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

EQ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -148.79%
Return-on-Assets % -109.44%
Profit Margin % -19.64%
Debt/Equity 0.00
Price/Sales 15.41
Price/Cash Flow N/A
Price/Book 2.98
Book Value/Share 0.51
Interest Coverage -0.35
60-Month Beta 1.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar